These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22714874)

  • 1. Obesity in multiracial schizophrenia patients receiving outpatient treatment in a regional tertiary hospital in malaysia.
    Norlelawati AT; Kartini A; Ramli M; Norsidah K; Wan Azizi WS; Tariq AR
    East Asian Arch Psychiatry; 2012 Jun; 22(2):49-56. PubMed ID: 22714874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
    Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
    Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, obesity, and psychopathology in patients with schizophrenia.
    Subramaniam M; Lam M; Guo ME; He VY; Lee J; Verma S; Chong SA
    J Clin Psychopharmacol; 2014 Feb; 34(1):40-6. PubMed ID: 24346756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
    Carpiniello B; Corda E; Maccioni R; Pinna F
    Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
    Tirupati S; Chua LE
    Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survey of obesity and underweight among inpatients with schizophrenia in psychiatric hospitals throughout Japan].
    Inamura Y; Sagae T; Kushida O; Nakamachi K; Murayama N
    Seishin Shinkeigaku Zasshi; 2013; 115(1):10-21. PubMed ID: 23691790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and its characteristics among obese patients attending an obesity clinic.
    Termizy HM; Mafauzy M
    Singapore Med J; 2009 Apr; 50(4):390-4. PubMed ID: 19421683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.
    Huang MC; Lu ML; Tsai CJ; Chen PY; Chiu CC; Jian DL; Lin KM; Chen CH
    Acta Psychiatr Scand; 2009 Oct; 120(4):274-80. PubMed ID: 19426161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
    Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
    J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates and distribution of body mass index in a sample of Malaysian adolescents.
    Zalilah MS; Mirnalini K; Khor GL; Merlin A; Bahaman AS; Norimah K
    Med J Malaysia; 2006 Mar; 61(1):48-58. PubMed ID: 16708734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk factors in drug-naive patients with first-episode psychosis.
    Verma SK; Subramaniam M; Liew A; Poon LY
    J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.